Melatonin treatment in peri- and postmenopausal women elevates serum high-density lipoprotein cholesterol levels without influencing total cholesterol levels
Article first published online: 19 FEB 2008
DOI: 10.1111/j.1600-079X.2008.00561.x
© 2008 The Authors. Journal compilation © 2008 Blackwell Munksgaard
Additional Information
How to Cite
Tamura, H., Nakamura, Y., Narimatsu, A., Yamagata, Y., Takasaki, A., Reiter, R. J. and Sugino, N. (2008), Melatonin treatment in peri- and postmenopausal women elevates serum high-density lipoprotein cholesterol levels without influencing total cholesterol levels. Journal of Pineal Research, 45: 101–105. doi: 10.1111/j.1600-079X.2008.00561.x
Publication History
- Issue published online: 14 JUL 2008
- Article first published online: 19 FEB 2008
- Received November 13, 2007; accepted December 17, 2007.
- Abstract
- Article
- References
- Cited By
Keywords:
- cardiovascular disease;
- high-density lipoprotein cholesterol;
- lipid metabolism;
- melatonin;
- menopause
Abstract: The purpose of this study was to investigate the effects of melatonin on lipid metabolism in peri- and postmenopausal women. Forty-six women were enrolled in these studies. The relationship between night-time serum melatonin levels and serum total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol was investigated in 36 women. Night-time serum melatonin levels had a negative correlation with serum total cholesterol and LDL-cholesterol, and a loose positive correlation with HDL-cholesterol. To examine the effects of exogenous melatonin on lipid metabolism, serum levels of total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides were determined in 10 women before the onset of therapy and after 1 month of oral melatonin administration (1 mg melatonin daily). Melatonin administration significantly increased the serum levels of HDL-cholesterol. These results show that melatonin may influence cholesterol metabolism and suggest that the melatonin administration may become a new medical application for improvement of lipid metabolism and prevention of cardiovascular disease in peri- and postmenopausal women.

1600-079X/asset/JPI_left.gif?v=1&s=11662d2aa0fa2fe9e6d2f9130a1b26b5b0b1c999)
